Sort
17,828 grants matching “crispr”
A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
$231,000Oliver None Hankinson · University Of California Los Angeles · R21 · FY2017 · ES
SMC1A/3 cohesin complex-mediated silencing of unintegrated HIV-1 DNA and the antagonism by Vpr
$231,000Yiping Zhu · University Of Rochester · R21 · FY2023 · AI
Function and mechanism of U21 in the Roseoloviruses
$231,000Amy W Hudson · Medical College Of Wisconsin · R21 · FY2017 · AI
CRISPR gRNA library screen of the HIV-1 genome
$231,000Kristine E Yoder · Ohio State University · R21 · FY2017 · AI
Developing zebra finch transgenic lines with functional receptors for VSV-G-pseudotyped lentiviruses
$231,000Claudio V Mello · Oregon Health & Science University · R21 · FY2020 · OD
Combinatorial engineering of a three-cell synthetic immunotherapy system
$231,000Kyle Gabriel Daniels · Stanford University · R21 · FY2025 · EB
Transcriptional regulation of ACE2 and the adaption of SARS-CoV-2
$231,000Yiping Zhu · University Of Rochester · R21 · FY2023 · AI
Identifying the molecular target for macrophage activation by chlorpyrifos
$231,000David B Jacoby · Oregon Health & Science University · R21 · FY2022 · AI
RESISTANCE AND RESPONSE SIGNALING TO PARP1 INHIBITORS IN OVARIAN CANCER
$230,992Alvaro N Monteiro · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2021 · CA
Mechanisms of MHCII expression and CD4+ T cell activation during Chlamydia trachomatis infection
$230,884Andrew Olive · Michigan State University · R21 · FY2021 · AI
Defining role of Long non-coding RNA (LncRNA) Gm15417 in iNKT development and subset differentiation
$230,866Jayati Basu · Cleveland Clinic Lerner Com-Cwru · R21 · FY2022 · AI
Development of novel diagnostics for African non-falciparum malaria
$230,805Jonathan Boyd Parr · Univ Of North Carolina Chapel Hill · R21 · FY2021 · AI
Reducing Diversity at the Gamma Protocadherin Locus by CRISPR Targeting
$230,739Robert W Burgess · Jackson Laboratory · R21 · FY2015 · NS
The role of linear ubiquitination in memory formation
$230,735Timothy Joseph Jarome · Virginia Polytechnic Inst And St Univ · R21 · FY2021 · MH
Project 1: Targeting Metastatic Prostate Cancer Patients with Biallelic Loss of CDK12
$230,649Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
Molecular Basis of Complement Defense in Choroidal Endothelial Cells
$230,501Budd A Tucker · University Of Iowa · R21 · FY2019 · EY
CRISPR/Cas9 approaches to model exfoliation syndrome
$230,501John H Fingert · University Of Iowa · R21 · FY2019 · EY
Pathogenic mechanisms of PACS2 syndrome variant in developing neurons
$230,395Alicia Dione Guemez Gamboa · Northwestern University At Chicago · R21 · FY2024 · NS
CANCAN - PENNINGTON
$230,310Justin C Brown · Lsu Pennington Biomedical Research Ctr · OT2 · FY2023 · CA
CRISPR and Virulence Core
$230,288Bridget Marie Barker · University Of California, San Francisco · U19 · FY2022 · AI
The role of non-coding variants in Usher disease
$230,277Debarshi Mustafi · University Of Washington · K08 · FY2023 · EY
The role of non-coding variants in Usher disease
$230,277Debarshi Mustafi · University Of Washington · K08 · FY2024 · EY
The role of non-coding variants in Usher disease
$230,277Debarshi Mustafi · University Of Washington · K08 · FY2025 · EY
GENOMICS AND GENOME ENGINEERING CORE
$230,256Kristen Lynn Jepsen · University Of California, San Diego · P50 · FY2016 · GM
Development of Transgenic Mouse Model Resources for Red Fluorescence-Based Genetically Encoded Indicator Studies
$230,250Pooneh Bagher · University Of Nebraska Medical Center · R21 · FY2025 · OD